POSC11 Systematic Literature Review and Network Meta-Analysis of Immunotherapy, Targeted Agents, or Combination Regimens in Treatment-Naive Unresectable or Metastatic Melanoma
Lee, J, Kuzmicheva, V, Lopatina, K, Barnieh, L, Janeiro, MJ, Sharma, R, Paranthaman, N
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study
Lewis, K., Robert, C., Ramella Munhoz, R., Liszkay, G., de la Cruz Merino, L., Olah, J., Queirolo, P., Mackiewicz, J., Li, H., Zhu, Q., Hertig, C., Paranthaman, N., McKenna, E.F., Gutzmer, R., McArthur, G., Ascierto, P.A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article